RDF/XML JSON-LD N3/Turtle RDF/JSON
Perfil en el portal institucional

Quintela Fandiño, Miguel Angel miguel.quintela@uam.es

Medicina / Universidad Autónoma de Madrid

Actividades

DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy

  • Quintela-Fandino, Miguel
  • Hitt, Ricardo
  • Medina, Pedro P.
  • Gamarra, Soledad
  • Manso, Luis
  • Cortes-Funes, Hernan
  • Sanchez-Cespedes, Montserrat;
... Ver más Contraer

Journal Of Clinical Oncology (p. 4333-4339) - 10/9/2006

10.1200/jco.2006.05.8768 Ver en origen

  • ISSN 0732183X

Prediction of Response to Targeted Therapies in Lung Cancer Using Dynamic Imaging: Still Far From Clinical Implementation

  • Quintela-Fandino, Miguel
  • Colomer, Ramon;

Journal Of Clinical Oncology (p. 3716-3718) - 20/9/2011

10.1200/jco.2011.37.1427 Ver en origen

  • ISSN 0732183X

p27(Kip1) V109G as a biomarker for CDK4/6 inhibitors indication in hormone receptor-positive breast cancer

  • Mouron, S
  • Bueno, MJ
  • Munoz, M
  • Torres, R
  • Rodriguez, S
  • Apala, JV
  • Silva, J
  • Sanchez-Bayona, R
  • Manso, L
  • Guerra, J
  • Rodriguez-Lajusticia, L
  • Malon, D
  • Malumbres, M
  • Quintela-Fandino, M
... Ver más Contraer

Jnci Cancer Spectrum - 1/4/2023

10.1093/jncics/pkad014

  • ISSN 25155091
  • iMarina

When should we order a next generation sequencing test in a patient with cancer?

  • Colomer R, Mondejar R, Romero-Laorden N, Alfranca A, Sanchez-Madrid F, Quintela-Fandino M

Eclinicalmedicine (p. 100487-100487) - 1/8/2020

10.1016/j.eclinm.2020.100487 Ver en origen

  • ISSN 25895370

Usefulness and real-world outcomes of next generation sequencing testing in patients with cancer: an observational study on the impact of selection based on clinical judgement

  • Colomer R
  • Miranda J
  • Romero-Laorden N
  • Hornedo J
  • González-Cortijo L
  • Mouron S
  • Bueno MJ
  • Mondéjar R
  • Quintela-Fandino M
... Ver más Contraer

Eclinicalmedicine - 1/6/2023

10.1016/j.eclinm.2023.102029 Ver en origen

  • ISSN 25895370

DOVITINIB LACTATE Multikinase Inhibitor Antiongiogenic Agent Oncolytic

  • Quintela-Fandino
  • M Colomer
  • R

Drugs Of The Future (p. 81-89) - 1/1/2013

10.1358/dof.2013.38.2.1918242 Ver en origen

  • ISSN 03778282

Mitochondrial Inhibition: a Treatment Strategy in Cancer?

  • Bueno, Maria J.
  • Ruiz-Sepulveda, Jose L.
  • Quintela-Fandino, Miguel;

Current Oncology Reports - 1/4/2021

10.1007/s11912-021-01033-x Ver en origen

  • ISSN 15233790

Antiangiogenic Resistance and Cancer Metabolism: Opportunities for Synthetic Lethality

  • Lord, Simon
  • Funes, Juan M.
  • Harris, Adrian L.
  • Quintela-Fandino, Miguel;

Current Drug Targets (p. 1714-1727) - 1/1/2016

10.2174/1389450117666160307143718 Ver en origen

  • ISSN 13894501

Revisiting the Revolution: Examining the Evolving Role of Antiangiogenic Therapy in Cancer

  • Quintela-Fandino, Miguel
  • Ebos, John M. L.;

Current Drug Targets (p. 1706-1706) - 1/1/2016

10.2174/1389450117999160425123635 Ver en origen

  • ISSN 13894501

Antiangiogenics and hypoxic response: Role of fatty acid synthase inhibitors

  • Bueno M
  • Sanchez J
  • Colomer R
  • Quintela-Fandino M

Current Drug Targets (p. 1735-1746) - 1/1/2016

10.2174/1389450117666160502151857 Ver en origen

  • ISSN 13894501

Este/a investigador/a no tiene libros.

Este/a investigador/a no tiene capítulos de libro.

Phase I clinical trial of neoadjuvant BIBF1120 plus weekly paclitaxel (P) in early HER-2 negative breast cancer. CNIO-BR-01-2010 GEICAM 2010-10 study

  • Quintela-Fandino, M.
  • Urruticoechea, A.
  • Guerra, J.
  • Gil, M.
  • Gonzalez-Martin, A.
  • Marquez, R.
  • Hernandez-Agudo, E.
  • Rodriguez-Martin, C.
  • Gil, M.
  • Bratos, R.
  • Escudero, M. J.
  • Colomer, R.;
... Ver más Contraer

Cancer Research - 15/12/2013

10.1158/0008-5472.sabcs13-pd5-8 Ver en origen

  • ISSN 00085472

Este/a investigador/a no tiene documentos de trabajo.

A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3K?/?, in Patients with Advanced Solid Tumors

  • Choudhury AD, Higano CS, de Bono JS, Cook N, Rathkopf DE, Wisinski KB, Martin-Liberal J, Linch M, Heath EI, Baird RD, García-Carbacho J, Quintela-Fandino M, Barry ST, de Bruin EC, Colebrook S, Hawkins G, Klinowska T, Maroj B, Moorthy G, Mortimer PG, Moschetta M, Nikolaou M, Sainsbury L, Shapiro GI, Siu LL, Hansen AR

Clinical Cancer Research (p. 2257-2269) - 1/1/2022

10.1158/1078-0432.ccr-21-3087 Ver en origen

  • ISSN 15573265

Este/a investigador/a no tiene proyectos de investigación.

Triple negative breast cancer kinome-taxonomy, prognostic and therapeutics: role of polynucleotide kinase-phosphatase

  • QUINTELA FANDIÑO, MIGUEL ANGEL (Director) Doctorando: Fernández Gaitero, Sara

4/3/2021

  • iMarina

Este/a investigador/a no tiene patentes o licencias de software.

Última actualización de los datos: 18/03/24 14:43